These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 9915326)
1. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326 [TBL] [Abstract][Full Text] [Related]
2. Interaction of local anaesthetics with recombinant mu, kappa, and delta-opioid receptors expressed in Chinese hamster ovary cells. Hirota K; Okawa H; Appadu BL; Grandy DK; Lambert DG Br J Anaesth; 2000 Nov; 85(5):740-6. PubMed ID: 11094591 [TBL] [Abstract][Full Text] [Related]
3. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase. Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor. Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors. Katsumata S; Minami M; Nakagawa T; Iwamura T; Satoh M Eur J Pharmacol; 1995 Nov; 291(3):367-73. PubMed ID: 8719422 [TBL] [Abstract][Full Text] [Related]
6. Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Law PY; McGinn TM; Campbell KM; Erickson LE; Loh HH Mol Pharmacol; 1997 Jan; 51(1):152-60. PubMed ID: 9016358 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors. Katsumata S; Ienaga Y; Minami M; Nakagawa T; Kanematsu K; Satoh M Eur J Pharmacol; 1996 Oct; 312(3):349-55. PubMed ID: 8894618 [TBL] [Abstract][Full Text] [Related]
8. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine. Townsend D; Portoghese PS; Brown DR J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex. Kim KW; Son Y; Shin BS; Cho KP Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997 [TBL] [Abstract][Full Text] [Related]
10. Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells. Fukuda K; Kato S; Shoda T; Morikawa H; Mima H; Mori K Anesth Analg; 1998 Aug; 87(2):450-5. PubMed ID: 9706949 [TBL] [Abstract][Full Text] [Related]
11. Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors. Knapp RJ; Landsman R; Waite S; Malatynska E; Varga E; Haq W; Hruby VJ; Roeske WR; Nagase H; Yamamura HI Eur J Pharmacol; 1995 Oct; 291(2):129-34. PubMed ID: 8566162 [TBL] [Abstract][Full Text] [Related]